Special Feature: Zuellig to bring Asian model to Australia
The $505 million purchase of Symbion Pharmacy Services by Hong Kong-headquartered pharma distribution business, Zuellig, brings to a close the uncertainty over control of Australia's third major full-line wholesaler. What does the future hold? » more
Breaking News- Posted 28 August Government legislation that would impose fees for PBS listing processes on the pharmaceutical industry has been rejected in the Senate by the narrowest of margins » full report
The Senate Community Affairs Committee has split along party lines in its report on the bill that would introduce fees for PBS listing activities, indicating the final decision will rest with Greens and independent senators » full report
The Federal Government is once again searching for someone to chair the Pharmaceutical Benefits Pricing Authority, only 18 months after appointing Dr Michael Nahan to the role » full report
The race to mount a class action against the TGA on behalf of individuals and business affected by the Pan recall is well and truly under way with a number of plaintiff lawyers said to be chasing the potentially lucrative prize » full report
Training systems for biopharmaceutical graduates are in line for a huge shake up following new data confirming the industry is facing a significant workforce shortage » full report
The College of Dermatologists has sworn to oppose a NDPSC attempt to allow GPs to prescribe controversial acne treatment, isotretinoin, best known as Roaccutane» full report
Bayer Schering Pharma will launch oral contraceptive YAZ in Australia this week with an indication for treatment of premenstrual
dysphoric disorder, a severe form of PMS » full report
Pathology company, Sonic Healthcare, is about to achieve its aim of 100% ownership of the country's biggest GP network with over 85 practices and close to 800 GPs under its umbrella » full report
GlaxoSmithKline's diabetes drug, Avandia, the subject of cardiovascular safety concerns over the past 12 months, has lost key indications and PBS funding » full report
People in Pharma
New faces at Nycomed, Agency moves
Nycomed has made two new senior sales and marketing appointments while two medical ad agencies have new bosses » full report
Your people moves
Nothing interests people in pharma more than what people in pharma are doing and where they're heading. Click here to spread your news » full report
In the wake of the Pan settlement, the complementary medicines sector on both sides of the Tasman is calling for an enquiry into the Therapeutic Goods Administration but, whatever the merits of the call, an enquiry almost certainly won't happen
» full report
